GR3005768T3 - - Google Patents

Info

Publication number
GR3005768T3
GR3005768T3 GR920401779T GR920401779T GR3005768T3 GR 3005768 T3 GR3005768 T3 GR 3005768T3 GR 920401779 T GR920401779 T GR 920401779T GR 920401779 T GR920401779 T GR 920401779T GR 3005768 T3 GR3005768 T3 GR 3005768T3
Authority
GR
Greece
Prior art keywords
remedying
prostaglandin
humans
preparations
deficiencies
Prior art date
Application number
GR920401779T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005768T3 publication Critical patent/GR3005768T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GR920401779T 1986-05-09 1992-09-24 GR3005768T3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863615710 DE3615710A1 (de) 1986-05-09 1986-05-09 Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen

Publications (1)

Publication Number Publication Date
GR3005768T3 true GR3005768T3 (cs) 1993-06-07

Family

ID=6300504

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401779T GR3005768T3 (cs) 1986-05-09 1992-09-24

Country Status (16)

Country Link
US (1) US5043328A (cs)
EP (1) EP0244832B1 (cs)
JP (1) JPS62267222A (cs)
KR (1) KR950008306B1 (cs)
AT (1) ATE77549T1 (cs)
AU (1) AU603574B2 (cs)
CA (1) CA1302266C (cs)
DE (2) DE3615710A1 (cs)
DK (1) DK167518B1 (cs)
ES (1) ES2051705T3 (cs)
GR (1) GR3005768T3 (cs)
HU (1) HU201671B (cs)
IE (1) IE60273B1 (cs)
IL (1) IL82459A (cs)
PT (1) PT84841B (cs)
ZA (1) ZA873299B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639828B1 (fr) * 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
NL9002438A (nl) * 1989-11-09 1991-06-03 Asta Pharma Ag Geneesmiddelen, welke als werkzame stof zwavel bevattende carbonzuren bevatten alsmede hun gebruik bij de bestrijding van retrovirussen.
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
CA2388754C (en) * 1999-10-13 2010-07-13 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
CA2389236A1 (en) * 1999-11-02 2001-05-10 Depomed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
US6228367B1 (en) * 1999-12-22 2001-05-08 Renew Life, Inc. Food supplement formulation
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
MXPA04012740A (es) * 2002-07-02 2005-03-23 Galileo Pharmaceuticals Inc Composiciones y metodos para reduccion de sintomas inflamatorios y/o biomarcadores en pacientes femeninos.
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
MXPA06013990A (es) * 2004-04-30 2007-08-14 Virtus Nutrition Llc Sintesis de sal de metal monovalente y divalente de acido graso polinsaturado.
WO2006054316A1 (en) * 2004-11-16 2006-05-26 Magene Life Sciences Private Limited Method(s) of preparation, stabilization, composition, and administration of gamma-linolenic acid for brain tumors
US20070082063A1 (en) * 2005-10-11 2007-04-12 Douglas Bibus Risk assessment and correction of membrane damage of the upper GI tract
EP2349250B1 (en) * 2008-10-31 2017-04-19 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
JP6038786B2 (ja) * 2010-07-22 2016-12-07 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドＲａｍｏｔ Ａｔ Ｔｅｌ Ａｖｉｖ Ｕｎｉｖｅｒｓｉｔｙ Ｌｔｄ． トリプトファン誘導体を含有する薬学的組成物
WO2013087808A1 (en) 2011-12-15 2013-06-20 Merz Pharma Gmbh & Co. Kgaa Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
JP6261565B2 (ja) 2012-04-16 2018-01-17 ローディア オペレーションズ フルオロポリマー組成物
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
WO2014138407A1 (en) * 2013-03-06 2014-09-12 Rutgers, The State University Of New Jersey Nutritional supplement/feed formula and methods of use thereof to reduce development of osteochondrosis dissecans (ocd) lesions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE237029C (cs) *
FR2197605A1 (en) * 1972-09-06 1974-03-29 Williams John Foodstuff or skin nutrient to combat cholesterolaemia - contains arachidonic acid or gamma linolenic acid or esters and salts thereof
JPS537492B2 (cs) * 1973-02-12 1978-03-18
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
DE2813814A1 (de) * 1978-03-31 1979-10-18 Boehringer Mannheim Gmbh Hochwirksame, enteral resorbierbare pharmazeutische praeparate
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
ATE22532T1 (de) * 1982-03-01 1986-10-15 Efamol Ltd Pharmazeutische zusammensetzung.
FR2522935A1 (fr) * 1982-03-10 1983-09-16 Chevalier Jacques Nouveaux produits a base de lait et de ses derives riches en acides gras polyinsatures et leur procede de preparation
JPS58164508A (ja) * 1982-03-26 1983-09-29 Eisai Co Ltd イソプレニルカルボン酸含有外用組成物
DE3366530D1 (en) * 1982-04-29 1986-11-06 Efamol Ltd Pharmaceutical composition
US4668704A (en) * 1982-08-09 1987-05-26 Regents Of The University Of California Method for protecting and healing gastro-duodenal mucosa and the liver of mammals
WO1984002271A1 (en) * 1982-12-09 1984-06-21 Hafsten Raymond J Jr Readily-absorpable fatty acid emulsions
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
GB2140806B (en) * 1983-05-28 1987-10-28 Sekimoto Hiroshi Stabilisation of unsaturated fatty acids, fish oils or fish
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
DE3470277D1 (en) * 1984-01-11 1988-05-11 Von Mletzko Armin Dietetic composition
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E

Also Published As

Publication number Publication date
US5043328A (en) 1991-08-27
ATE77549T1 (de) 1992-07-15
DE3779958D1 (de) 1992-07-30
PT84841A (de) 1987-06-01
AU7264187A (en) 1987-11-12
ES2051705T3 (es) 1994-07-01
EP0244832A3 (en) 1989-11-29
HUT44433A (en) 1988-03-28
AU603574B2 (en) 1990-11-22
KR870010867A (ko) 1987-12-18
JPS62267222A (ja) 1987-11-19
EP0244832A2 (de) 1987-11-11
DK235687A (da) 1987-11-10
CA1302266C (en) 1992-06-02
EP0244832B1 (de) 1992-06-24
ZA873299B (en) 1987-11-02
DE3615710A1 (de) 1987-11-26
HU201671B (en) 1990-12-28
PT84841B (pt) 1990-02-08
IL82459A0 (en) 1987-11-30
DK235687D0 (da) 1987-05-08
IE60273B1 (en) 1994-06-29
DK167518B1 (da) 1993-11-15
IL82459A (en) 1994-07-31
KR950008306B1 (ko) 1995-07-27
IE871203L (en) 1987-11-09

Similar Documents

Publication Publication Date Title
GR3005768T3 (cs)
NO880268D0 (no) Fremgangsmaate for fremstilling av anti-koagulerende peptider.
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
DE3682882D1 (de) Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung.
AU7595194A (en) Use of antigenic substances for the prophylaxis or therapy of disorders and diseases within the gastrointestinal tract of animals and humans
NO881510D0 (no) Sterilt formeringssystem.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
NO880292L (no) Fremgangsmaate for behandling av humle.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
FI872459A7 (fi) Farmaseuttinen valmiste bakteeri-infektioiden hoitoon.
NO884792D0 (no) Fremgangsmaate for fremstilling av alfa-olefinpolymer.
GR3005231T3 (cs)
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
FI875232A0 (fi) Anordning foer foerflyttning av maenniska, saerskilt en roerelsebegraensad patient.
NO884921D0 (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
AU1705783A (en) Medicine for the treatment of the neoplazic disease
NO912230D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive anellerte dihydropyridinyleddiksyrer.
NO885058L (no) 6-oxoprostaglandin-e-derivater, fremgangsmaater for fremstilling av disse og deres farmasoeytiske anvendelse.
IT8785543A0 (it) Posizionatore per la preparazionedi cofani funebri.
IT7826606A0 (it) Impianto per la sterilizzazione di farine animali e simili.